About The Journal ISSN: 2249-622X
Asian Journal of Biomedical and Pharmaceutical Sciences
ISSN: 2249 – 622X
Google Scholar H-Index: 16
Journal Impact Factor: 0.96 | 5 Years Impact Factor: 2.64
Current Issue: Volume 12 Issue 91
Dr. Francisco Lopez-Munoz,
International Doctoral School,
Universidad Camilo Jose Cela,
Next issue: Volume 12 Issue 92
The journal publishes scholarly articles on the systems, policies, and practices that promote research and innovations in Biomedical and Pharmaceutical Sciences. This includes research in following fields
Anatomy, Physiology, Biochemistry, Molecular Biology, Cell biology, Genetics, Hematology, Pathology, Immunology, Microbiology, Virology, Parasitology, Surgery, Dental Sciences, Sports Physiology, Histopathology, Toxicology and all major disciplines of Biomedical Sciences.
Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Pharmacology and Toxicology, Pharmaceutical and Biomedical Analysis, Clinical Research, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology and all major disciplines of Pharmaceutical Sciences.
Articles are published as they are accepted and are freely available on the journal’s website to facilitate rapid and broad dissemination of research findings to a global audience.
Top Reasons for publication with us
Quick Quality Review: The journal has strong international team of editors and reviewers.
Rapid Decision and Publication: We guarantee a review of your manuscript by a panel of qualified experts within 21 days of submission. Authors that need a faster decision can request Fast Track review and get a response in 5-7 business days.
Low Publication Fees: Comparable journals charge a huge sum for each accepted manuscript. AJBPS only charges the fees necessary to recoup costs associated with running the journal.
Other features: DOI Assigned, Plagiarism Check by Ithenicate, Implemented the Rapid Open Review System (ORS).
You may submit manuscripts online through following link https://www.scholarscentral.org/submissions/asian-biomedical-pharmaceutical-sciences.html or as an email attachment to the following Mail Id: [email protected]
Fast Editorial Execution and Review Process (FEE-Review Process):
Asian Journal of Biomedical and Pharmaceutical Sciences is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.